Chapter 1. Research Background
1.1. Research Objectives
1.2. Market Definition
1.3. Research Scope
1.3.1. Market Segmentation by Product
1.3.2. Market Segmentation by Application
1.3.3. Market Segmentation by End User
1.3.4. Market Segmentation by Geography
1.3.5. Analysis Period
1.3.6. Market Data Reporting Unit
1.3.6.1. Value
1.4. Key Stakeholders
Chapter 2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.2.1. Breakdown of Primary Research Respondents
2.2.1.1. By region
2.2.1.2. By industry participants
2.2.1.3. By company type
2.3. Market Size Estimation
2.4. Market Breakdown and Data Triangulation
2.5. Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1. Market Segmentation
4.1.1. Overview by Product
4.1.1.1. Albumin
4.1.1.2. Coagulation factor concentrates
4.1.1.3. Immunoglobulin
4.1.1.4. Protease inhibitors
4.1.1.5. Others
4.1.2. Overview by Application
4.1.2.1. Neurology
4.1.2.2. Immunology
4.1.2.3. Hematology
4.1.2.4. Pulmonology
4.1.2.5. Hemato-oncology
4.1.2.6. Rheumatology
4.1.2.7. Critical care
4.1.2.8. Others
4.1.3. Overview by End User
4.1.3.1. Hospitals and clinics
4.1.3.2. Clinical research laboratories
4.1.3.3. Others
4.2. Market Dynamics
4.2.1. Trends
4.2.2. Drivers
4.2.2.1. Impact analysis of drivers on market forecast
4.2.3. Restraints
4.2.3.1. Impact analysis of restraints on market forecast
4.2.4. Opportunities
4.3. Porter’s Five Forces Analysis
Chapter 5. Market Size and Forecast by Product
5.1. Albumin
5.2. Coagulation Factor Concentrates
5.3. Immunoglobulin
5.4. Protease Inhibitors
5.5. Others
Chapter 6. Market Size and Forecast by Application
6.1. Neurology
6.2. Immunology
6.3. Hematology
6.4. Pulmonology
6.5. Hemato-Oncology
6.6. Rheumatology
6.7. Critical Care
6.8. Others
Chapter 7. Market Size and Forecast by End User
7.1. Hospitals and Clinics
7.2. Clinical Research Laboratories
7.3. Others
Chapter 8. Market Size and Forecast by Geography
8.1. North America Blood Plasma Product Market
8.1.1. By Product
8.1.2. By Application
8.1.3. By End User
8.1.4. By Country – The U.S. and Canada
8.2. Europe Blood Plasma Product Market
8.2.1. By Product
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country –Germany, The U.K., France, Italy, Spain and Rest of Europe
8.3. Asia-Pacific Blood Plasma Product Market
8.3.1. By Product
8.3.2. By Application
8.3.3. By End User
8.3.4. By Country –China, Japan, India and Rest of Asia-Pacific
8.4. Latin America Blood Plasma Product Market
8.4.1. By Product
8.4.2. By Application
8.4.3. By End User
8.5. Middle East & Africa Blood Plasma Product Market
8.5.1. By Product
8.5.2. By Application
8.5.3. By End User
Chapter 9. Competitive Landscape
9.1. Competitive Analysis of Key Players
9.2. Global Strategic Developments
Chapter 10. Company Profiles
10.1. CSL Ltd.
10.1.1. Business Overview
10.1.2. Product and Service Offerings
10.1.3. Key Financial Summary
10.1.4. Strategic Growth Plan
10.2. Grifols S.A.
10.2.1. Business Overview
10.2.2. Product and Service Offerings
10.2.3. Key Financial Summary
10.2.4. Strategic Growth Plan
10.3. Shire PLS
10.3.1. Business Overview
10.3.2. Product and Service Offerings
10.3.3. Key Financial Summary
10.3.4. Strategic Growth Plan
10.4. Octapharma AG
10.4.1. Business Overview
10.4.2. Product and Service Offerings
10.4.3. Key Financial Summary
10.4.4. Strategic Growth Plan
10.5. Kedrion S.p.A
10.5.1. Business Overview
10.5.2. Product and Service Offerings
10.5.3. Key Financial Summary
10.5.4. Strategic Growth Plan
10.6. Biotest AG
10.6.1. Business Overview
10.6.2. Product and Service Offerings
10.6.3. Key Financial Summary
10.6.4. Strategic Growth Plan
10.7. China Biologic Products, Inc.
10.7.1. Business Overview
10.7.2. Product and Service Offerings
10.7.3. Key Financial Summary
10.7.4. Strategic Growth Plan
10.8. Sanquin
10.8.1. Business Overview
10.8.2. Product and Service Offerings
10.8.3. Key Financial Summary
10.8.4. Strategic Growth Plan
10.9. LFB S.A.
10.9.1. Business Overview
10.9.2. Product and Service Offerings
10.9.3. Key Financial Summary
10.9.4. Strategic Growth Plan
10.10. Bio Products Laboratory Ltd.
10.10.1. Business Overview
10.10.2. Product and Service Offerings
10.10.3. Key Financial Summary
10.10.4. Strategic Growth Plan
*Note: Key financial summary and strategic growth plan will be provided on best effort basis and is subject to availability during primary and secondary research.
Chapter 11. Appendix
11.1. Abbreviations
